NF-kappaB: Pivotal Mediator or Innocent Bystander in Atherogenesis?

J Clin Invest. 2001 Feb;107(3):255-64. doi: 10.1172/JCI10373.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Aorta / metabolism
  • Aorta / pathology
  • Apoptosis
  • Arteriosclerosis / etiology*
  • Arteriosclerosis / metabolism
  • Arteriosclerosis / pathology
  • Diabetes Complications
  • Endothelium, Vascular / metabolism
  • Endothelium, Vascular / microbiology
  • Hemodynamics
  • Homocysteine / metabolism
  • Humans
  • Hypertension / complications
  • Leukocytes / physiology
  • NF-kappa B / physiology*
  • Oxidative Stress
  • Risk Factors
  • Vascular Cell Adhesion Molecule-1 / biosynthesis

Substances

  • NF-kappa B
  • Vascular Cell Adhesion Molecule-1
  • Homocysteine